TMPRSS2 and prostate adenocarcinoma: Given that the study focused on the expression of TMPRSS2 and showed that the expression of TMPRSS2 is higher in both normal and cancerous tissues from PRAD, clinical relationship between TMPRSS2 expression and survival outcomes was also examined.